All In Biotech

Drug Trial Radar · NCT07948005

A Long-Term Follow-Up Study of Subjects With Stargardt Disease (STGD1) Treated With SB-007

A Long-Term Follow-Up Study of Subjects With Stargardt Disease Type 1 (STGD1) Previously Treated With SB-007

Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

55

Planned (sponsor's estimate)

Start

Dec 1, 2026

Primary completion

Dec 31, 2035

Study completion Dec 31, 2035

Sponsor

Lead sponsor
Splice BioIndustry
Sponsor type
Industry
First posted
Nov 19, 2026

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the long-term safety of subretinal SB-007 administration in subjects with Stargardt Disease Type 1 (STGD1). This is a multicenter study which will follow subjects over a 164-week period after completion of an antecedent SB-007 interventional trial.

Conditions

  • Stargardt Disease
  • Stargardt Macular Degeneration
  • Stargardt Macular Dystrophy

Interventions

  • No new interventionDrug

    This is an observational long-term follow-up (LTFU) study of subjects with STGD1 who were previously treated with SB-007 in an antecedent SB-007 interventional trial. There is no new intervention involved in this LTFU study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Long-term safety of SB-007Time frame: 164 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.